{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:44:46Z","timestamp":1793313886835,"version":"4.5.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["AIRC SIS 30262"],"award-info":[{"award-number":["AIRC SIS 30262"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["AIRC SIS 30262"],"award-info":[{"award-number":["AIRC SIS 30262"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Italian Ministry of Health, Ricerca Corrente 2025"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The MAFB protein, a member of the MAF family of bZip transcription factors, plays a pivotal role in various biological processes, including cell differentiation, development, and homeostasis. Characterized by its selective expression in monocytes and macrophages, MAFB has been shown to play a crucial role during myeloid lineage differentiation, acting as a critical determinant in the transition from multipotent progenitors to fully differentiated monocytes. By modulating the expression of genes associated with immune activation and inflammation, MAFB plays a vital role in maintaining immune homeostasis and responding to pathogenic challenges. Dysregulation of MAFB expression or function has been implicated in several pathological conditions, including hematological malignancies and metabolic disorders. In particular, aberrant MAFB activity has been associated with the progression of diseases such as multiple myeloma and acute myeloid leukemia as well as other solid tumors, where it may contribute to the survival and proliferation of malignant cells, thereby promoting disease progression. MAFB and downstream targets of its transcriptional network are now being regarded as predictive biomarkers for certain types of tumors as well as being considered as potential therapeutic targets for cancer treatment. In this review, we summarize current knowledge on both physiological and pathological roles of MAFB and highlight the impact of its deregulation on hematological cancer initiation and progression.<\/jats:p>","DOI":"10.1038\/s41420-025-02551-4","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T11:52:04Z","timestamp":1749729124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["MAFB: a key regulator of myeloid commitment involved in hematological diseases"],"prefix":"10.1038","volume":"11","author":[{"given":"Antonio Benedetto","family":"Ventura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Loconte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Negri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Viggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6764-9395","authenticated-orcid":false,"given":"Giuseppe","family":"Fiermonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0223-8402","authenticated-orcid":false,"given":"Sabino","family":"Ciavarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Guarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5000-6951","authenticated-orcid":false,"given":"Giacomo","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"2551_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/0042-6822(92)90532-T","volume":"188","author":"S Kawai","year":"1992","unstructured":"Kawai S, Goto N, Kataoka K, Saegusa T, Shinno-Kohno H, Nishizawa M. Isolation of the avian transforming retrovirus, AS42, carrying the v-maf oncogene and initial characterization of its gene product. Virology. 1992;188:778\u201384.","journal-title":"Virology"},{"key":"2551_CR2","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.1073\/pnas.86.20.7711","volume":"86","author":"M Nishizawa","year":"1989","unstructured":"Nishizawa M, Kataoka K, Goto N, Fujiwara KT, Kawai S. v-maf, a viral oncogene that encodes a \u201cleucine zipper\u201d motif. Proc Natl Acad Sci USA. 1989;86:7711\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2551_CR3","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.1128\/MCB.00001-06","volume":"26","author":"T Moriguchi","year":"2006","unstructured":"Moriguchi T, Hamada M, Morito N, Terunuma T, Hasegawa K, Zhang C, et al. MafB is essential for renal development and F4\/80 expression in macrophages. Mol Cell Biol. 2006;26:5715\u201327.","journal-title":"Mol Cell Biol"},{"key":"2551_CR4","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1128\/MCB.23.17.6049-6062.2003","volume":"23","author":"TA Matsuoka","year":"2003","unstructured":"Matsuoka TA, Zhao L, Artner I, Jarrett HW, Friedman D, Means A, et al. Members of the large Maf transcription family regulate insulin gene transcription in islet beta cells. Mol Cell Biol. 2003;23:6049\u201362.","journal-title":"Mol Cell Biol"},{"key":"2551_CR5","doi-asserted-by":"publisher","first-page":"12263","DOI":"10.1074\/jbc.M210801200","volume":"278","author":"SE Samaras","year":"2003","unstructured":"Samaras SE, Zhao L, Means A, Henderson E, Matsuoka TA, Stein R. The islet beta cell-enriched RIPE3b1\/Maf transcription factor regulates pdx-1 expression. J Biol Chem. 2003;278:12263\u201370.","journal-title":"J Biol Chem"},{"key":"2551_CR6","doi-asserted-by":"publisher","first-page":"6737","DOI":"10.1073\/pnas.102168499","volume":"99","author":"M Olbrot","year":"2002","unstructured":"Olbrot M, Rud J, Moss LG, Sharma A. Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc Natl Acad Sci USA. 2002;99:6737\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2551_CR7","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/sj.onc.1200869","volume":"14","author":"M Sakai","year":"1997","unstructured":"Sakai M, Imaki J, Yoshida K, Ogata A, Matsushima-Hibaya Y, Kuboki Y, et al. Rat maf related genes: specific expression in chondrocytes, lens and spinal cord. Oncogene. 1997;14:745\u201350.","journal-title":"Oncogene"},{"key":"2551_CR8","first-page":"2679","volume":"38","author":"K Yoshida","year":"1997","unstructured":"Yoshida K, Imaki J, Koyama Y, Harada T, Shinmei Y, Oishi C, et al. Differential expression of maf-1 and maf-2 genes in the developing rat lens. Invest Ophthalmol Vis Sci. 1997;38:2679\u201383.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2551_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1126\/science.280.5360.115","volume":"280","author":"H Ogino","year":"1998","unstructured":"Ogino H, Yasuda K. Induction of lens differentiation by activation of a bZIP transcription factor, L-Maf. Science. 1998;280:115\u20138.","journal-title":"Science"},{"key":"2551_CR10","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.jid.2016.05.088","volume":"136","author":"M Miyai","year":"2016","unstructured":"Miyai M, Hamada M, Moriguchi T, Hiruma J, Kamitani-Kawamoto A, Watanabe H, et al. Transcription factor MafB coordinates epidermal keratinocyte differentiation. J Invest Dermatol. 2016;136:1848\u201357.","journal-title":"J Invest Dermatol"},{"key":"2551_CR11","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1111\/exd.13364","volume":"26","author":"M Miyai","year":"2017","unstructured":"Miyai M, Tsunekage Y, Saito M, Kohno K, Takahashi K, Kataoka K. Ectopic expression of the transcription factor MafB in basal keratinocytes induces hyperproliferation and perturbs epidermal homeostasis. Exp Dermatol. 2017;26:1039\u201345.","journal-title":"Exp Dermatol"},{"key":"2551_CR12","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.devcel.2015.01.028","volume":"32","author":"V Lopez-Pajares","year":"2015","unstructured":"Lopez-Pajares V, Qu K, Zhang J, Webster DE, Barajas BC, Siprashvili Z, et al. A LncRNA-MAF:MAFB transcription factor network regulates epidermal differentiation. Dev Cell. 2015;32:693\u2013706.","journal-title":"Dev Cell"},{"key":"2551_CR13","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1182\/blood-2006-09-048249","volume":"109","author":"K Kim","year":"2007","unstructured":"Kim K, Kim JH, Lee J, Jin HM, Kook H, Kim KK, et al. MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood. 2007;109:3253\u20139.","journal-title":"Blood"},{"key":"2551_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0012-1606(03)00324-5","volume":"262","author":"HE MacLean","year":"2003","unstructured":"MacLean HE, Kim JI, Glimcher MJ, Wang J, Kronenberg HM, Glimcher LH. Absence of transcription factor c-maf causes abnormal terminal differentiation of hypertrophic chondrocytes during endochondral bone development. Dev Biol. 2003;262:51\u201363.","journal-title":"Dev Biol"},{"key":"2551_CR15","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.bbrc.2005.11.119","volume":"339","author":"K Omoteyama","year":"2006","unstructured":"Omoteyama K, Ikeda H, Imaki J, Sakai M. Activation of connective tissue growth factor gene by the c-Maf and Lc-Maf transcription factors. Biochem Biophys Res Commun. 2006;339:1089\u201397.","journal-title":"Biochem Biophys Res Commun"},{"key":"2551_CR16","first-page":"700","volume":"14","author":"K Kataoka","year":"1994","unstructured":"Kataoka K, Noda M, Nishizawa M. Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Mol Cell Biol. 1994;14:700\u201312.","journal-title":"Mol Cell Biol"},{"key":"2551_CR17","first-page":"2371","volume":"8","author":"KT Fujiwara","year":"1993","unstructured":"Fujiwara KT, Kataoka K, Nishizawa M. Two new members of the maf oncogene family, mafK and mafF, encode nuclear b-Zip proteins lacking putative trans-activator domain. Oncogene. 1993;8:2371\u201380.","journal-title":"Oncogene"},{"key":"2551_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1349-7006.2006.00358.x","volume":"98","author":"H Motohashi","year":"2007","unstructured":"Motohashi H, Yamamoto M. Carcinogenesis and transcriptional regulation through Maf recognition elements. Cancer Sci. 2007;98:135\u20139.","journal-title":"Cancer Sci"},{"key":"2551_CR19","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1128\/MCB.15.4.2180","volume":"15","author":"K Kataoka","year":"1995","unstructured":"Kataoka K, Igarashi K, Itoh K, Fujiwara KT, Noda M, Yamamoto M, et al. Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor. Mol Cell Biol. 1995;15:2180\u201390.","journal-title":"Mol Cell Biol"},{"key":"2551_CR20","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.bbamcr.2012.06.012","volume":"1823","author":"MB Kannan","year":"2012","unstructured":"Kannan MB, Solovieva V, Blank V. The small MAF transcription factors MAFF, MAFG and MAFK: current knowledge and perspectives. Biochim Biophys Acta. 2012;1823:1841\u20136.","journal-title":"Biochim Biophys Acta"},{"key":"2551_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/oxfordjournals.jbchem.a002825","volume":"129","author":"M Kajihara","year":"2001","unstructured":"Kajihara M, Kawauchi S, Kobayashi M, Ogino H, Takahashi S, Yasuda K. Isolation, characterization, and expression analysis of zebrafish large Mafs. J Biochem. 2001;129:139\u201346.","journal-title":"J Biochem"},{"key":"2551_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/sj.onc.1201898","volume":"17","author":"S Benkhelifa","year":"1998","unstructured":"Benkhelifa S, Provot S, Lecoq O, Pouponnot C, Calothy G, Felder-Schmittbuhl MP. mafA, a novel member of the maf proto-oncogene family, displays developmental regulation and mitogenic capacity in avian neuroretina cells. Oncogene. 1998;17:247\u201354.","journal-title":"Oncogene"},{"key":"2551_CR23","first-page":"7581","volume":"14","author":"K Kataoka","year":"1994","unstructured":"Kataoka K, Fujiwara KT, Noda M, Nishizawa M. MafB, a new Maf family transcription activator that can associate with Maf and Fos but not with Jun. Mol Cell Biol. 1994;14:7581\u201391.","journal-title":"Mol Cell Biol"},{"key":"2551_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1073\/pnas.89.1.266","volume":"89","author":"A Swaroop","year":"1992","unstructured":"Swaroop A, Xu JZ, Pawar H, Jackson A, Skolnick C, Agarwal N. A conserved retina-specific gene encodes a basic motif\/leucine zipper domain. Proc Natl Acad Sci USA. 1992;89:266\u201370.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2551_CR25","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/0092-8674(94)90033-7","volume":"79","author":"SP Cordes","year":"1994","unstructured":"Cordes SP, Barsh GS. The mouse segmentation gene kr encodes a novel basic domain-leucine zipper transcription factor. Cell. 1994;79:1025\u201334.","journal-title":"Cell"},{"key":"2551_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1567-133X(03)00152-2","volume":"4","author":"L Lecoin","year":"2004","unstructured":"Lecoin L, Sii-Felice K, Pouponnot C, Eychene A, Felder-Schmittbuhl MP. Comparison of maf gene expression patterns during chick embryo development. Gene Expr Patterns. 2004;4:35\u201346.","journal-title":"Gene Expr Patterns"},{"key":"2551_CR27","first-page":"3149","volume":"9","author":"TK Kerppola","year":"1994","unstructured":"Kerppola TK, Curran T. A conserved region adjacent to the basic domain is required for recognition of an extended DNA binding site by Maf\/Nrl family proteins. Oncogene. 1994;9:3149\u201358.","journal-title":"Oncogene"},{"key":"2551_CR28","first-page":"675","volume":"9","author":"TK Kerppola","year":"1994","unstructured":"Kerppola TK, Curran T. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun. Oncogene. 1994;9:675\u201384.","journal-title":"Oncogene"},{"key":"2551_CR29","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S0092-8674(00)00190-2","volume":"103","author":"H Motohashi","year":"2000","unstructured":"Motohashi H, Katsuoka F, Shavit JA, Engel JD, Yamamoto M. Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins. Cell. 2000;103:865\u201375.","journal-title":"Cell"},{"key":"2551_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(02)00788-6","volume":"294","author":"H Motohashi","year":"2002","unstructured":"Motohashi H, O\u2019Connor T, Katsuoka F, Engel JD, Yamamoto M. Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene. 2002;294:1\u201312.","journal-title":"Gene"},{"key":"2551_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbaexp.2005.12.005","volume":"1759","author":"C Vinson","year":"2006","unstructured":"Vinson C, Acharya A, Taparowsky EJ. Deciphering B-ZIP transcription factor interactions in vitro and in vivo. Biochim Biophys Acta. 2006;1759:4\u201312.","journal-title":"Biochim Biophys Acta"},{"key":"2551_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0968-0004(97)01105-5","volume":"22","author":"V Blank","year":"1997","unstructured":"Blank V, Andrews NC. The Maf transcription factors: regulators of differentiation. Trends Biochem Sci. 1997;22:437\u201341.","journal-title":"Trends Biochem Sci"},{"key":"2551_CR33","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/emboj\/20.4.828","volume":"20","author":"M Dlakic","year":"2001","unstructured":"Dlakic M, Grinberg AV, Leonard DA, Kerppola TK. DNA sequence-dependent folding determines the divergence in binding specificities between Maf and other bZIP proteins. EMBO J. 2001;20:828\u201340.","journal-title":"EMBO J"},{"key":"2551_CR34","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nsb771","volume":"9","author":"H Kusunoki","year":"2002","unstructured":"Kusunoki H, Motohashi H, Katsuoka F, Morohashi A, Yamamoto M, Tanaka T. Solution structure of the DNA-binding domain of MafG. Nat Struct Biol. 2002;9:252\u20136.","journal-title":"Nat Struct Biol"},{"key":"2551_CR35","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1093\/nar\/gki653","volume":"33","author":"T Yoshida","year":"2005","unstructured":"Yoshida T, Ohkumo T, Ishibashi S, Yasuda K. The 5\u2019-AT-rich half-site of Maf recognition element: a functional target for bZIP transcription factor Maf. Nucleic Acids Res. 2005;33:3465\u201378.","journal-title":"Nucleic Acids Res"},{"key":"2551_CR36","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrc2460","volume":"8","author":"A Eychene","year":"2008","unstructured":"Eychene A, Rocques N, Pouponnot C. A new MAFia in cancer. Nat Rev Cancer. 2008;8:683\u201393.","journal-title":"Nat Rev Cancer"},{"key":"2551_CR37","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0378-1119(99)00500-4","volume":"242","author":"K Huang","year":"2000","unstructured":"Huang K, Serria MS, Nakabayashi H, Nishi S, Sakai M. Molecular cloning and functional characterization of the mouse mafB gene. Gene. 2000;242:419\u201326.","journal-title":"Gene"},{"key":"2551_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40164-020-00197-9","volume":"10","author":"Z Wu","year":"2021","unstructured":"Wu Z, Nicoll M, Ingham RJ. AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+ ALCL. Exp Hematol Oncol. 2021;10:4.","journal-title":"Exp Hematol Oncol"},{"key":"2551_CR39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.23861\/EJBM20072347","volume":"23","author":"Y Yang","year":"2007","unstructured":"Yang Y, Cvekl A. Large Maf transcription factors: cousins of AP-1 proteins and important regulators of cellular differentiation. Einstein J Biol Med. 2007;23:2\u201311.","journal-title":"Einstein J Biol Med"},{"key":"2551_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0092-8674(00)81081-8","volume":"85","author":"MH Sieweke","year":"1996","unstructured":"Sieweke MH, Tekotte H, Frampton J, Graf T. MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell. 1996;85:49\u201360.","journal-title":"Cell"},{"key":"2551_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0925-4773(97)00063-4","volume":"65","author":"A Eichmann","year":"1997","unstructured":"Eichmann A, Grapin-Botton A, Kelly L, Graf T, Le Douarin NM, Sieweke M. The expression pattern of the mafB\/kr gene in birds and mice reveals that the kreisler phenotype does not represent a null mutant. Mech Dev. 1997;65:111\u201322.","journal-title":"Mech Dev"},{"key":"2551_CR42","first-page":"486","volume":"11 Suppl 3","author":"MH Sieweke","year":"1997","unstructured":"Sieweke MH, Tekotte H, Frampton J, Graf T. MafB represses erythroid genes and differentiation through direct interaction with c-Ets-1. Leukemia. 1997;11 Suppl 3:486\u20138.","journal-title":"Leukemia"},{"key":"2551_CR43","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/emboj\/19.9.1987","volume":"19","author":"LM Kelly","year":"2000","unstructured":"Kelly LM, Englmeier U, Lafon I, Sieweke MH, Graf T. MafB is an inducer of monocytic differentiation. EMBO J. 2000;19:1987\u201397.","journal-title":"EMBO J"},{"key":"2551_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.it.2007.01.006","volume":"28","author":"A Dakic","year":"2007","unstructured":"Dakic A, Wu L, Nutt SL. Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?. Trends Immunol. 2007;28:108\u201314.","journal-title":"Trends Immunol"},{"key":"2551_CR45","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1182\/blood-2004-04-1448","volume":"105","author":"Y Bakri","year":"2005","unstructured":"Bakri Y, Sarrazin S, Mayer UP, Tillmanns S, Nerlov C, Boned A, et al. Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate. Blood. 2005;105:2707\u201316.","journal-title":"Blood"},{"key":"2551_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/intimm\/dxab103","volume":"34","author":"H Saiga","year":"2022","unstructured":"Saiga H, Ueno M, Tanaka T, Kaisho T, Hoshino K. Transcription factor MafB-mediated inhibition of type I interferons in plasmacytoid dendritic cells. Int Immunol. 2022;34:159\u201372.","journal-title":"Int Immunol"},{"key":"2551_CR47","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/sj.cdd.4401679","volume":"12","author":"M Montanari","year":"2005","unstructured":"Montanari M, Gemelli C, Tenedini E, Zanocco Marani T, Vignudelli T, Siena M, et al. Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors. Cell Death Differ. 2005;12:1588\u2013600.","journal-title":"Cell Death Differ"},{"key":"2551_CR48","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/sj.cdd.4401860","volume":"13","author":"C Gemelli","year":"2006","unstructured":"Gemelli C, Montanari M, Tenedini E, Zanocco Marani T, Vignudelli T, Siena M, et al. Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem\/progenitor cells. Cell Death Differ. 2006;13:1686\u201396.","journal-title":"Cell Death Differ"},{"key":"2551_CR49","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/leu.2016.289","volume":"31","author":"M Clarke","year":"2017","unstructured":"Clarke M, Volpe G, Sheriff L, Walton D, Ward C, Wei W, et al. Transcriptional regulation of SPROUTY2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3. Leukemia. 2017;31:957\u201366.","journal-title":"Leukemia"},{"key":"2551_CR50","doi-asserted-by":"publisher","first-page":"e0138257","DOI":"10.1371\/journal.pone.0138257","volume":"10","author":"G Volpe","year":"2015","unstructured":"Volpe G, Clarke M, Garcia P, Walton DS, Vegiopoulos A, Del Pozzo W, et al. Regulation of the Flt3 gene in haematopoietic stem and early progenitor cells. PLoS ONE. 2015;10:e0138257.","journal-title":"PLoS ONE"},{"key":"2551_CR51","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1128\/MCB.01811-06","volume":"27","author":"S Tillmanns","year":"2007","unstructured":"Tillmanns S, Otto C, Jaffray E, Du Roure C, Bakri Y, Vanhille L, et al. SUMO modification regulates MafB-driven macrophage differentiation by enabling Myb-dependent transcriptional repression. Mol Cell Biol. 2007;27:5554\u201364.","journal-title":"Mol Cell Biol"},{"key":"2551_CR52","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1126\/science.1176056","volume":"326","author":"A Aziz","year":"2009","unstructured":"Aziz A, Soucie E, Sarrazin S, Sieweke MH. MafB\/c-Maf deficiency enables self-renewal of differentiated functional macrophages. Science. 2009;326:867\u201371.","journal-title":"Science"},{"key":"2551_CR53","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.1128\/MCB.00245-06","volume":"26","author":"A Aziz","year":"2006","unstructured":"Aziz A, Vanhille L, Mohideen P, Kelly LM, Otto C, Bakri Y, et al. Development of macrophages with altered actin organization in the absence of MafB. Mol Cell Biol. 2006;26:6808\u201318.","journal-title":"Mol Cell Biol"},{"key":"2551_CR54","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.cell.2009.04.057","volume":"138","author":"S Sarrazin","year":"2009","unstructured":"Sarrazin S, Mossadegh-Keller N, Fukao T, Aziz A, Mourcin F, Vanhille L, et al. MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells. Cell. 2009;138:300\u201313.","journal-title":"Cell"},{"key":"2551_CR55","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/sj.onc.1209171","volume":"25","author":"C Pouponnot","year":"2006","unstructured":"Pouponnot C, Sii-Felice K, Hmitou I, Rocques N, Lecoin L, Druillennec S, et al. Cell context reveals a dual role for Maf in oncogenesis. Oncogene. 2006;25:1299\u2013310.","journal-title":"Oncogene"},{"key":"2551_CR56","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1158\/0008-5472.CAN-05-2154","volume":"66","author":"N Morito","year":"2006","unstructured":"Morito N, Yoh K, Fujioka Y, Nakano T, Shimohata H, Hashimoto Y, et al. Overexpression of c-Maf contributes to T-cell lymphoma in both mice and human. Cancer Res. 2006;66:812\u20139.","journal-title":"Cancer Res"},{"key":"2551_CR57","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1097\/PAS.0b013e318054dbcf","volume":"31","author":"YI Murakami","year":"2007","unstructured":"Murakami YI, Yatabe Y, Sakaguchi T, Sasaki E, Yamashita Y, Morito N, et al. c-Maf expression in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2007;31:1695\u2013702.","journal-title":"Am J Surg Pathol"},{"key":"2551_CR58","doi-asserted-by":"publisher","first-page":"7931","DOI":"10.1038\/sj.onc.1206527","volume":"22","author":"M Nishizawa","year":"2003","unstructured":"Nishizawa M, Fu SL, Kataoka K, Vogt PK. Artificial oncoproteins: modified versions of the yeast bZip protein GCN4 induce cellular transformation. Oncogene. 2003;22:7931\u201341.","journal-title":"Oncogene"},{"key":"2551_CR59","doi-asserted-by":"publisher","first-page":"7882","DOI":"10.1038\/sj.onc.1206526","volume":"22","author":"M Nishizawa","year":"2003","unstructured":"Nishizawa M, Kataoka K, Vogt PK. MafA has strong cell transforming ability but is a weak transactivator. Oncogene. 2003;22:7882\u201390.","journal-title":"Oncogene"},{"key":"2551_CR60","doi-asserted-by":"publisher","first-page":"34074","DOI":"10.1074\/jbc.M105383200","volume":"276","author":"K Kataoka","year":"2001","unstructured":"Kataoka K, Handa H, Nishizawa M. Induction of cellular antioxidative stress genes through heterodimeric transcription factor Nrf2\/small Maf by antirheumatic gold(I) compounds. J Biol Chem. 2001;276:34074\u201381.","journal-title":"J Biol Chem"},{"key":"2551_CR61","doi-asserted-by":"publisher","first-page":"36849","DOI":"10.1074\/jbc.M102234200","volume":"276","author":"K Kataoka","year":"2001","unstructured":"Kataoka K, Shioda S, Yoshitomo-Nakagawa K, Handa H, Nishizawa M. Maf and Jun nuclear oncoproteins share downstream target genes for inducing cell transformation. J Biol Chem. 2001;276:36849\u201356.","journal-title":"J Biol Chem"},{"key":"2551_CR62","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1074\/jbc.M007643200","volume":"276","author":"K Kataoka","year":"2001","unstructured":"Kataoka K, Yoshitomo-Nakagawa K, Shioda S, Nishizawa M. A set of Hox proteins interact with the Maf oncoprotein to inhibit its DNA binding, transactivation, and transforming activities. J Biol Chem. 2001;276:819\u201326.","journal-title":"J Biol Chem"},{"key":"2551_CR63","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","volume":"111","author":"RA Kyle","year":"2008","unstructured":"Kyle RA, Rajkumar SV. Multiple myeloma. Blood. 2008;111:2962\u201372.","journal-title":"Blood"},{"key":"2551_CR64","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/hon.2586","volume":"37","author":"SV Rajkumar","year":"2019","unstructured":"Rajkumar SV. Multiple myeloma: every year a new standard?. Hematol Oncol. 2019;37:62\u20135.","journal-title":"Hematol Oncol"},{"key":"2551_CR65","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrc746","volume":"2","author":"WM Kuehl","year":"2002","unstructured":"Kuehl WM, Bergsagel PL. Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer. 2002;2:175\u201387.","journal-title":"Nat Rev Cancer"},{"key":"2551_CR66","doi-asserted-by":"crossref","unstructured":"Kuehl WM, Bergsagel PL. Early genetic events provide the basis for a clinical classification of multiple myeloma. Hematology Am Soc Hematol Educ Program. 2005;2005:346\u201352.","DOI":"10.1182\/asheducation-2005.1.346"},{"key":"2551_CR67","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.beha.2007.08.004","volume":"20","author":"WJ Chng","year":"2007","unstructured":"Chng WJ, Glebov O, Bergsagel PL, Kuehl WM. Genetic events in the pathogenesis of multiple myeloma. Best Pract Res Clin Haematol. 2007;20:571\u201396.","journal-title":"Best Pract Res Clin Haematol"},{"key":"2551_CR68","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1182\/blood.V91.12.4457.412k48_4457_4463","volume":"91","author":"M Chesi","year":"1998","unstructured":"Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, et al. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood. 1998;91:4457\u201363.","journal-title":"Blood"},{"key":"2551_CR69","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1349-7006.2001.tb01142.x","volume":"92","author":"I Hanamura","year":"2001","unstructured":"Hanamura I, Iida S, Akano Y, Hayami Y, Kato M, Miura K, et al. Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations. Jpn J Cancer Res. 2001;92:638\u201344.","journal-title":"Jpn J Cancer Res"},{"key":"2551_CR70","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2141.2004.05050.x","volume":"126","author":"GR Boersma-Vreugdenhil","year":"2004","unstructured":"Boersma-Vreugdenhil GR, Kuipers J, Van Stralen E, Peeters T, Michaux L, Hagemeijer A, et al. The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint. Br J Haematol. 2004;126:355\u201363.","journal-title":"Br J Haematol"},{"key":"2551_CR71","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3960\/jslrt.19011","volume":"59","author":"T Murase","year":"2019","unstructured":"Murase T, Inagaki A, Masaki A, Fujii K, Narita T, Ri M, et al. Plasma cell myeloma positive for t(14;20) with relapse in the central nervous system. J Clin Exp Hematop. 2019;59:135\u20139.","journal-title":"J Clin Exp Hematop"},{"key":"2551_CR72","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1111\/cas.14109","volume":"110","author":"T Murase","year":"2019","unstructured":"Murase T, Ri M, Narita T, Fujii K, Masaki A, Iida S, et al. Immunohistochemistry for identification of CCND1, NSD2, and MAF gene rearrangements in plasma cell myeloma. Cancer Sci. 2019;110:2600\u20136.","journal-title":"Cancer Sci"},{"key":"2551_CR73","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1349-7006.2003.tb01445.x","volume":"94","author":"K Miura","year":"2003","unstructured":"Miura K, Iida S, Hanamura I, Kato M, Banno S, Ishida T, et al. Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia. Cancer Sci. 2003;94:350\u20134.","journal-title":"Cancer Sci"},{"key":"2551_CR74","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.1038\/sj.onc.1208844","volume":"24","author":"A Suzuki","year":"2005","unstructured":"Suzuki A, Iida S, Kato-Uranishi M, Tajima E, Zhan F, Hanamura I, et al. ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma. Oncogene. 2005;24:6936\u201344.","journal-title":"Oncogene"},{"key":"2551_CR75","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1182\/blood.V99.6.2185","volume":"99","author":"H Avet-Loiseau","year":"2002","unstructured":"Avet-Loiseau H, Facon T, Grosbois B, Magrangeas F, Rapp MJ, Harousseau JL, et al. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation. Blood. 2002;99:2185\u201391.","journal-title":"Blood"},{"key":"2551_CR76","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2002-08-2436","volume":"101","author":"H Avet-Loiseau","year":"2003","unstructured":"Avet-Loiseau H, Garand R, Lode L, Harousseau JL, Bataille R. Intergroupe Francophone du M. Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants. Blood. 2003;101:1570\u20131.","journal-title":"Blood"},{"key":"2551_CR77","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","volume":"108","author":"F Zhan","year":"2006","unstructured":"Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S, et al. The molecular classification of multiple myeloma. Blood. 2006;108:2020\u20138.","journal-title":"Blood"},{"key":"2551_CR78","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2005-01-0034","volume":"106","author":"PL Bergsagel","year":"2005","unstructured":"Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B, Shaughnessy J Jr. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood. 2005;106:296\u2013303.","journal-title":"Blood"},{"key":"2551_CR79","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","volume":"109","author":"JD Shaughnessy Jr","year":"2007","unstructured":"Shaughnessy JD Jr, Zhan F, Burington BE, Huang Y, Colla S, Hanamura I, et al. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood. 2007;109:2276\u201384.","journal-title":"Blood"},{"key":"2551_CR80","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1038\/emboj.2012.227","volume":"31","author":"C Vicente-Duenas","year":"2012","unstructured":"Vicente-Duenas C, Romero-Camarero I, Gonzalez-Herrero I, Alonso-Escudero E, Abollo-Jimenez F, Jiang X, et al. A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors. EMBO J. 2012;31:3704\u201317.","journal-title":"EMBO J"},{"key":"2551_CR81","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415\u201321.","journal-title":"Nature"},{"key":"2551_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7997","volume":"6","author":"BA Walker","year":"2015","unstructured":"Walker BA, Wardell CP, Murison A, Boyle EM, Begum DB, Dahir NM, et al. APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma. Nat Commun. 2015;6:6997.","journal-title":"Nat Commun"},{"key":"2551_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2013.67","volume":"4","author":"NI Herath","year":"2014","unstructured":"Herath NI, Rocques N, Garancher A, Eychene A, Pouponnot C. GSK3-mediated MAF phosphorylation in multiple myeloma as a potential therapeutic target. Blood Cancer J. 2014;4:e175.","journal-title":"Blood Cancer J"},{"key":"2551_CR84","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.molcel.2007.11.009","volume":"28","author":"N Rocques","year":"2007","unstructured":"Rocques N, Abou Zeid N, Sii-Felice K, Lecoin L, Felder-Schmittbuhl MP, Eychene A, et al. GSK-3-mediated phosphorylation enhances Maf-transforming activity. Mol Cell. 2007;28:584\u201397.","journal-title":"Mol Cell"},{"key":"2551_CR85","doi-asserted-by":"publisher","first-page":"9709","DOI":"10.1002\/cam4.5679","volume":"12","author":"K Abe","year":"2023","unstructured":"Abe K, Ikeda S, Nara M, Kitadate A, Tagawa H, Takahashi N. Hypoxia-induced oxidative stress promotes therapy resistance via upregulation of heme oxygenase-1 in multiple myeloma. Cancer Med. 2023;12:9709\u201322.","journal-title":"Cancer Med"},{"key":"2551_CR86","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1074\/jbc.RA119.010724","volume":"295","author":"Y He","year":"2020","unstructured":"He Y, Wang S, Tong J, Jiang S, Yang Y, Zhang Z, et al. The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival. J Biol Chem. 2020;295:2084\u201396.","journal-title":"J Biol Chem"},{"key":"2551_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.450","volume":"8","author":"S Wang","year":"2017","unstructured":"Wang S, Juan J, Zhang Z, Du Y, Xu Y, Tong J, et al. Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis. Cell Death Dis. 2017;8:e3058.","journal-title":"Cell Death Dis"},{"key":"2551_CR88","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1182\/bloodadvances.2023009772","volume":"7","author":"A Katsarou","year":"2023","unstructured":"Katsarou A, Trasanidis N, Ponnusamy K, Kostopoulos IV, Alvarez-Benayas J, Papaleonidopoulou F, et al. MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesis. Blood Adv. 2023;7:6395\u2013410.","journal-title":"Blood Adv"},{"key":"2551_CR89","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.exphem.2008.08.006","volume":"37","author":"E van Stralen","year":"2009","unstructured":"van Stralen E, van de Wetering M, Agnelli L, Neri A, Clevers HC, Bast BJ. Identification of primary MAFB target genes in multiple myeloma. Exp Hematol. 2009;37:78\u201386.","journal-title":"Exp Hematol"},{"key":"2551_CR90","first-page":"1750","volume":"118","author":"RE Tiedemann","year":"2008","unstructured":"Tiedemann RE, Mao X, Shi CX, Zhu YX, Palmer SE, Sebag M, et al. Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity. J Clin Invest. 2008;118:1750\u201364.","journal-title":"J Clin Invest"},{"key":"2551_CR91","doi-asserted-by":"publisher","first-page":"6202","DOI":"10.1182\/blood-2010-06-292243","volume":"117","author":"P Neri","year":"2011","unstructured":"Neri P, Ren L, Azab AK, Brentnall M, Gratton K, Klimowicz AC, et al. Integrin beta7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion. Blood. 2011;117:6202\u201313.","journal-title":"Blood"},{"key":"2551_CR92","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1182\/blood-2007-05-093294","volume":"110","author":"S Vallet","year":"2007","unstructured":"Vallet S, Raje N, Ishitsuka K, Hideshima T, Podar K, Chhetri S, et al. MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts. Blood. 2007;110:3744\u201352.","journal-title":"Blood"},{"key":"2551_CR93","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1517\/14728222.2011.586634","volume":"15","author":"S Vallet","year":"2011","unstructured":"Vallet S, Anderson KC. CCR1 as a target for multiple myeloma. Expert Opin Ther Targets. 2011;15:1037\u201347.","journal-title":"Expert Opin Ther Targets"},{"key":"2551_CR94","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/ajh.21864","volume":"86","author":"M Lutherborrow","year":"2011","unstructured":"Lutherborrow M, Bryant A, Jayaswal V, Agapiou D, Palma C, Yang YH, et al. Expression profiling of cytogenetically normal acute myeloid leukemia identifies microRNAs that target genes involved in monocytic differentiation. Am J Hematol. 2011;86:2\u201311.","journal-title":"Am J Hematol"},{"key":"2551_CR95","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.3109\/10428194.2015.1015123","volume":"56","author":"L Yang","year":"2015","unstructured":"Yang L, Liu Y, Zhu L, Xiao M. DNMT3A R882 mutation is associated with elevated expression of MAFB and M4\/M5 immunophenotype of acute myeloid leukemia blasts. Leuk Lymphoma. 2015;56:2914\u201322.","journal-title":"Leuk Lymphoma"},{"key":"2551_CR96","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1038\/s41375-021-01307-0","volume":"35","author":"M Gourvest","year":"2021","unstructured":"Gourvest M, De Clara E, Wu HC, Touriol C, Meggetto F, De The H, et al. A novel leukemic route of mutant NPM1 through nuclear import of the overexpressed long noncoding RNA LONA. Leukemia. 2021;35:2784\u201398.","journal-title":"Leukemia"},{"key":"2551_CR97","doi-asserted-by":"crossref","unstructured":"Volpe G, Cauchy P, Walton DS, Ward C, Blakemore D, Bayley R, et al. Dependence on Myb expression is attenuated in myeloid leukaemia with N-terminal CEBPA mutations. Life Sci Alliance. 2019;2:e201800207.","DOI":"10.26508\/lsa.201800207"},{"key":"2551_CR98","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/leu.2013.23","volume":"27","author":"G Volpe","year":"2013","unstructured":"Volpe G, Walton DS, Del Pozzo W, Garcia P, Dasse E, O\u2019Neill LP, et al. C\/EBPalpha and MYB regulate FLT3 expression in AML. Leukemia. 2013;27:1487\u201396.","journal-title":"Leukemia"},{"key":"2551_CR99","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1182\/blood.2022019138","volume":"141","author":"ML Clarke","year":"2023","unstructured":"Clarke ML, Lemma RB, Walton DS, Volpe G, Noyvert B, Gabrielsen OS, et al. MYB insufficiency disrupts proteostasis in hematopoietic stem cells, leading to age-related neoplasia. Blood. 2023;141:1858\u201370.","journal-title":"Blood"},{"key":"2551_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06276-z","volume":"14","author":"A Negri","year":"2023","unstructured":"Negri A, Ward C, Bucci A, D\u2019Angelo G, Cauchy P, Radesco A, et al. Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML. Cell Death Dis. 2023;14:763.","journal-title":"Cell Death Dis"},{"key":"2551_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2023.149135","volume":"684","author":"K Asano","year":"2023","unstructured":"Asano K, Kikuchi K, Takehara M, Ogasawara M, Yoshioka Y, Ohnishi K, et al. Identification of small compounds that inhibit multiple myeloma proliferation by targeting c-Maf transcriptional activity. Biochem Biophys Res Commun. 2023;684:149135.","journal-title":"Biochem Biophys Res Commun"},{"key":"2551_CR102","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2020.01.039","volume":"479","author":"MV Yusenko","year":"2020","unstructured":"Yusenko MV, Trentmann A, Andersson MK, Ghani LA, Jakobs A, Arteaga Paz MF, et al. Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells. Cancer Lett. 2020;479:61\u201370.","journal-title":"Cancer Lett"},{"key":"2551_CR103","doi-asserted-by":"crossref","unstructured":"Takao S, Forbes L, Uni M, Cheng S, Pineda JMB, Tarumoto Y, et al. Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia. Elife. 2021;10:e65905.","DOI":"10.7554\/eLife.65905"},{"key":"2551_CR104","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00018-023-04745-4","volume":"80","author":"AG de la Aleja","year":"2023","unstructured":"de la Aleja AG, Herrero C, Torres-Torresano M, Schiaffino MT, Del Castillo A, Alonso B, et al. Inhibition of LXR controls the polarization of human inflammatory macrophages through upregulation of MAFB. Cell Mol Life Sci. 2023;80:96.","journal-title":"Cell Mol Life Sci"},{"key":"2551_CR105","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/hon.3050","volume":"40","author":"MC Vegliante","year":"2022","unstructured":"Vegliante MC, Mazzara S, Zaccaria GM, De Summa S, Esposito F, Melle F, et al. NR1H3 (LXRalpha) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma. Hematol Oncol. 2022;40:864\u201375.","journal-title":"Hematol Oncol"},{"key":"2551_CR106","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00018-024-05196-1","volume":"81","author":"B Lopez-Navarro","year":"2024","unstructured":"Lopez-Navarro B, Simon-Fuentes M, Rios I, Schiaffino MT, Sanchez A, Torres-Torresano M, et al. Macrophage re-programming by JAK inhibitors relies on MAFB. Cell Mol Life Sci. 2024;81:152.","journal-title":"Cell Mol Life Sci"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02551-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02551-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02551-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:02:38Z","timestamp":1749772958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-025-02551-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2551"],"URL":"https:\/\/doi.org\/10.1038\/s41420-025-02551-4","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors affiliated to the IRCCS Istituto Tumori \u201cGiovanni Paolo II\u201d, Bari are responsible for the views expressed in this article, which do not necessarily represent the Institute. The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"276"}}